Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000769734-26-000056·CASTLE BIOSCIENCES INC
Schedule 13G ownership disclosure
Castle Biosciences Inc
Common Stock, $0.001 par value per share · CUSIP: 14843C105
Event date: 2026-09-30
- Filing-level shares
- 1,500,897
- Percent of class
- 4.9%
- PRINCIPAL GLOBAL INVESTORS
Shares: 1,500,897 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769734-26-000056
- Form type
- SCHEDULE 13G/A
- Filer
- CASTLE BIOSCIENCES INC
- CIK
- CIK 1447362
- Filed
- Oct 29, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership